Ferring B.V. et al v. Allergan Inc. et al, No. 1:2012cv02650 - Document 241 (S.D.N.Y. 2016)

Court Description: OPINION re: 227 MOTION in Limine / NOTICE OF ALLERGAN'S MOTION IN LIMINE #2: TO EXCLUDE OPINIONS AND OTHER TESTIMONY OF RIKARD SANDSTROM. filed by Allergan Sales, LLC, Allergan USA, Inc., Allergan Inc., 225 MOTION in Limine / NOTICE OF ALLERGAN'S MOTION IN LIMINE #1: TO EXCLUDE TESTIMONY OR EVIDENCE RELATING TO BUSINESS NEGOTIATIONS AND DUE DILIGENCE PRECEDING THE MARCH 2010 AGREEMENT BETWEEN ALLERGAN, SERENITY, AND REPRISE. filed by Allergan Sales , LLC, Allergan USA, Inc., Allergan Inc. The motion in limine of Allergan to preclude evidence of due diligence and by Sandstrom is granted in part and denied in part as set forth above. It is so ordered. (As further set forth in this order) (Signed by Judge Robert W. Sweet on 10/28/2016) (lmb)